Robert Weaver - Researcher Profile | RDL Research Database

Publications

2 shown

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

Ralph Zinner , Coleman K. Obasaju , David R. Spigel +16 more

2014 Journal of Thoracic Oncology 170 citations

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia , Sara A. Hurvitz , Sara M. Tolaney +27 more

Progression-free and overall survival were significantly longer with sacituzumab govitecan than with single-agent chemotherapy among patients with metastatic triple-negative bre...

2021 New England Journal of Medicine 1301 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,471
Institution: Florida Cancer Specialists & Research Institute

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.

Publications

Frequent Co-Authors

Researcher Info

External Links

Impact Metrics

Academic Output Over Time